The hepatic inflammation response is a crucial feature of NAFLD, and the canonical TLR4/NF-κB inflammatory pathway has been identified as a critical contributor in the advancement of NAFLD (Tang et al. 2023). The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.